Rhenman & Partners Asset Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,750
Closed -$545K 95
2024
Q4
$545K Sell
13,750
-92,000
-87% -$4.15M 0.06% 91
2024
Q3
$6.71M Buy
105,750
+65,926
+166% +$4.76M 0.54% 59
2024
Q2
$2.69M Buy
39,824
+27,200
+215% +$1.9M 0.26% 71
2024
Q1
$1M Sell
12,624
-6,000
-32% -$491K 0.09% 83
2023
Q4
$1.45M Buy
+18,624
New +$1.38M 0.14% 79

Other funds holding ACHC

Rhenman & Partners Asset Management's ACHC Position: Q1 2025 in Review

Rhenman & Partners Asset Management sold out of Acadia Healthcare (ACHC) in Q1 2025, closing a stake of 13,750 shares — an estimated $545K sold.

Rhenman & Partners Asset Management first reported a position in ACHC in Q4 2023 and held it in 5 quarters. The position peaked at $6.71M in Q3 2024. 292 funds tracked by Wall St. Rank hold ACHC as of Q1 2025.

  • Rhenman & Partners Asset Management reported no remaining Acadia Healthcare position as of Q1 2025 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 13,750 Acadia Healthcare shares in Q1 2025, an estimated $545K.
  • Rhenman & Partners Asset Management first reported a position in Acadia Healthcare in Q4 2023 and held it in 5 quarters.
  • Rhenman & Partners Asset Management's Acadia Healthcare position peaked at $6.71M in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2025.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2025, filed 14 May 2025.